DS
AUPH icon

DRW Securities’s Aurinia Pharmaceuticals AUPH Stock Holding History

DRW Securities’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-10,000
Closed -$124K – 251
2022
Q1 		$124K Sell
10,000
-25,200
-72% -$389K ﹤0.01% 262
2021
Q4 		$805K Buy
+35,200
New +$834K 0.02% 106

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DRW Securities's AUPH Position: Q2 2026 in Review

DRW Securities opened a new position in Aurinia Pharmaceuticals (AUPH) in Q2 2026: 22,294 shares worth $378K. The stake represents 0.01% of the portfolio and ranks #502 among its holdings. This is a return to the name: DRW Securities previously reported a position in AUPH as recently as Q2 2025.

DRW Securities first reported a position in AUPH in Q1 2018 and has held it in 7 quarters since. The position peaked at $482K in Q1 2023. 283 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • DRW Securities held 22,294 shares of Aurinia Pharmaceuticals worth $378K as of Q2 2026.
  • Aurinia Pharmaceuticals was a new DRW Securities position in Q2 2026.
  • Aurinia Pharmaceuticals made up 0.01% of DRW Securities's portfolio in Q2 2026, its #502 holding.
  • DRW Securities first reported a position in Aurinia Pharmaceuticals in Q1 2018 and has held it in 7 quarters since.
  • DRW Securities's Aurinia Pharmaceuticals position peaked at $482K in Q1 2023.
  • 283 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on DRW Securities's 13F filing for Q2 2026, filed 14 Aug 2026.